Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation

For cells of the innate immune system to mount a host defence response to infection, they must recognize products of microbial pathogens such as lipopolysaccharide (LPS), the endotoxin secreted by Gram-negative bacteria1. These cellular responses require intracellular signalling pathways, such as the four MAP kinase (MAPK) pathways2–6. In mammalian cells the MAPK p38 is thought to play an important role in the regulation of cellular responses during infection through its effects on the expression of proinflammatory molecules7–9. One means of understanding the role of p38 in these responses is to identify proteins with functions regulated by p38-catalysed phosphorylation. Here we demonstrate a link between the p38 pathway and a member of the myocyte-enhancer factor 2 (MEF2) group of transcription factors. We found that in monocytic cells, LPS increases the transactivation activity of MEF2C10–12 through p38-catalysed phosphorylation. One consequence of MEF2C activation is increased c-jun gene transcription. Our results show that p38 may influence host defence and inflammation by maintaining the balance of c-Jun protein consumed during infection.

[1]  R. Erikson,et al.  Activation of protein serine/threonine kinases p42, p63, and p87 in Rous sarcoma virus-transformed cells: signal transduction/transformation-dependent MBP kinases. , 1992, Molecular biology of the cell.

[2]  S. Lipton,et al.  MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Cobb,et al.  Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro. , 1993, The Journal of biological chemistry.

[4]  Jiahuai Han,et al.  Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level [published erratum appears in J Exp Med 1990 Mar 1;171(3):971-2] , 1990, The Journal of experimental medicine.

[5]  N. Mackman,et al.  Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites , 1991, The Journal of experimental medicine.

[6]  A. DeFranco,et al.  Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  K. Blumer,et al.  Diversity in function and regulation of MAP kinase pathways. , 1994, Trends in biochemical sciences.

[8]  A. Deisseroth,et al.  Interaction of nuclear proteins with an AP‐1/CRE‐like promoter sequence in the human TNF‐α gene , 1994 .

[9]  Jiahuai Han,et al.  Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and Threonine (*) , 1995, The Journal of Biological Chemistry.

[10]  J. Martín,et al.  Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Wei Guo,et al.  Characterization of the Structure and Function of a New Mitogen-activated Protein Kinase (p38β)* , 1996, The Journal of Biological Chemistry.

[12]  W. Fiers,et al.  The p38/RK mitogen‐activated protein kinase pathway regulates interleukin‐6 synthesis response to tumor necrosis factor. , 1996, The EMBO journal.

[13]  M. Shin,et al.  Definition of a lipopolysaccharide-responsive element in the 5'-flanking regions of MuRantes and crg-2 , 1994, Molecular and cellular biology.

[14]  R. Prywes,et al.  Regulatory role of MEF2D in serum induction of the c-jun promoter , 1995, Molecular and cellular biology.

[15]  L Bibbs,et al.  A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. , 1994, Science.

[16]  J. Martín,et al.  Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C , 1996, Molecular and cellular biology.

[17]  Jiahuai Han,et al.  Primary structure of BMK1: a new mammalian map kinase. , 1995, Biochemical and biophysical research communications.

[18]  M. Karin,et al.  JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain , 1994, Cell.

[19]  C. Natanson,et al.  Bacterial endotoxins and pathogenesis of Gram-negative infections: current status and future direction , 1994 .

[20]  T. Suzuki,et al.  Mechanism of lipopolysaccharide-triggered junB activation in a mouse macrophage-like cell line (J774). , 1993, The Journal of biological chemistry.

[21]  Jiahuai Han,et al.  Characterization of the Structure and Function of a Novel MAP Kinase Kinase (MKK6) (*) , 1996, The Journal of Biological Chemistry.

[22]  Jerry L. Adams,et al.  A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.

[23]  T. Hunter,et al.  Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. , 1991, Methods in enzymology.

[24]  Gaochao Zhou,et al.  Components of a New Human Protein Kinase Signal Transduction Pathway (*) , 1995, The Journal of Biological Chemistry.

[25]  S. Lipton,et al.  hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors , 1993, Molecular and cellular biology.

[26]  S. Elledge,et al.  The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. , 1993, Genes & development.